Explore BFLY stock analysis with latest price, earnings, technicals, and forecast. Is BFLY stock a buy? Get balanced insights on Butterfly Network for investors.
Introduction
Butterfly Network makes handheld ultrasound devices using chip technology. This lets doctors scan patients anywhere with a smartphone app.
Investors watch BFLY stock now due to recent earnings beats and revenue jumps.
Tech stocks face headwinds from high rates, but medtech grows on AI demand.
Latest Stock Price & Trend
BFLY stock closed at $4.37, up sharply on volume. One-day gain hit 46% amid options buzz.
Over five days, it climbed from recent lows around $2.40. The one-month trend shows volatility, down 37% from January peaks near $4.87 but rebounding.
Three-month performance rose 52% from November lows. Six-month surge reached 112%. Year-to-date, it’s down 19% but off lows.
The 52-week range spans $1.32 low to $4.98 high. This bullish short-term trend signals momentum, but pullbacks loom for investors.
Technical Analysis
Support sits near $3.50, a recent bounce point. Resistance looms at $5.00, the yearly high.
RSI at 70 shows overbought conditions, risking a cool-off; it measures speed of price moves. MACD at -0.115 hints bearish short-term momentum, tracking trend shifts.
The 50-day moving average hovers above price, while 200-day lags; no golden cross yet. Volume spiked on up days, confirming interest.
These point to caution after rally; watch for breaks.
Analyst Ratings & Price Targets
Three analysts rate BFLY a Strong Buy. Average target is $3.50, with highs at $4.00 and lows $2.25.
Craig-Hallum cut to $3.00 in July 2025. Lake Street held Buy at $4.
Positive sentiment reflects growth bets, aiding investor confidence.
Insider Activity
Insiders bought far more than sold recently; 19.9M shares bought vs 3.5M sold in last trades.
June 2025 saw directors buy 80k shares each. CEO DeVivo sold 443k in March but bought 1.2M earlier.
Net buying shows management confidence in upside.
Valuation Analysis
Trailing P/E stays negative at N/A due to -$0.34 EPS losses. Forward P/E unavailable; focus on sales.
Price-to-sales around 8x on $88M TTM revenue. YoY revenue grew 33% last quarter. EPS improved but negative.
Free cash flow negative; cash strong with 4.8 current ratio, low debt. Vs peers like Zoom, BFLY trades cheaper on sales but riskier on losses.
Stock looks fairly valued for growth medtech play.
Recent Earnings & Catalysts
Q4 2025 revenue hit record $31.5M, up 41% YoY, beating views. EPS beat by $0.02 at -$0.04 last quarter.
Guidance strong on partnerships; US sales up 55%. Midjourney co-dev added $6.8M.
Earnings drove 50% stock pop; AI ultrasound integrations key catalyst.
Bullish Case
Revenue grows from iQ3 probe adoption and cloud subs.
Demand rises in point-of-care ultrasound market. Chip tech cuts costs vs rivals.
Enterprise deals and AI tools boost margins.
Bearish Case
Competition from GE, Philips pressures share. Losses persist at -$80M TTM.
Margin squeezes if growth slows; high beta amplifies downturns. Regulatory hurdles in global expansion add risk.
Market Sentiment
Short interest at 9.72% of float, 2.44 days to cover. Call options dominate recent activity.
Institutions own 56%, down slightly but steady. Retail piles in on momentum.
Sentiment turns optimistic post-earnings.
Short-Term Outlook
Technicals show overbought RSI, high volume. Momentum strong but due for pause.
Expect sideways action next weeks unless catalysts hit.
Medium to Long-Term Outlook
Solid model in expanding ultrasound space. Financials improving with cash buffer.
Competitive edge in portability; watch execution. Long-term investors should hold or accumulate on dips.
FAQ
Is BFLY stock a buy right now? Strong Buy rating, but volatile; suits risk-tolerant.
What is the price target for BFLY stock? Average $3.50, up 30% potential.
What are major risks for BFLY stock? Losses, competition, market swings.
BFLY earnings outlook? Revenue growth strong, profitability path key.
Suggestions
Compare with Opendoor stock analysis.
See our Microsoft stock forecast.
Read tech medtech valuation breakdown.
Final Balanced Conclusion
Hold BFLY stock. Growth shines, but losses and volatility warrant caution. Watch earnings for buy signals.
Disclaimer: This article is for informational purposes only and not financial advice.